Marcel Botha, CEO of 10XBeta, discusses shortcomings in the US's emergency plans for rapid innovation and manufacturing ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Of the total trade in FY24, Indian exports to the US stood at $77.5 billion, while US exports to India stood at $40.7 billion. America is the third largest investor in India with cumulative FDI ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

In a survey of 200 healthcare industry experts, 82% said they expect tariff-related import expenses to increase hospital and ...

Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

Download Roadmap The healthcare sector, while focused on improving human health, is a contributor to environmental impacts.

Navigating compliance challenges and technology solutions under DSCSA.

The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.